December 7, 2022
Cannabidiol-C4

Cannabis in Psychiatry According to John J. Miller, MD

Read Time:55 Second

by Emily Jianetto

Source: HCP Live

John J. Miller is an experienced psychiatrist and in an interview with HCPLive, he explained his view of cannabis’s place in psychiatry. Interestingly, Dr. Miller’s most significant problem is with the word cannabis itself. He states that the word cannabis is a ‘“very vague and general term”’ (Walter). The effects marijuana has on someone are contingent upon the percentage of THC or CBD present in the product, but the word cannabis does not account for that (Walter). Since many modern studies simply use the word cannabis without any breakdown of the contents of cannabis, it is harder to apply the results of the said study (Walter).

Delta-9-tetrahydrocannabinol via Wikimedia Commons

With that said, Dr. Miller does believe there is evidence to support that CBD could benefit conditions such as psychosis, depression, and anxiety (Walter). This has been shown in clinical trials, and tests with CBD molecules (Walter). However, according to Dr. Miller, the key to further improving the efficacies of these studies is to specify the THC and CBD contents of cannabis (Walter). 

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %